Eric Topol

So we've watched these three initiatives that I think you were involved in.

UK Biobank, which has had more impact than any cohort ever assembled.

Every day, there's another paper using that data.

Yeah, yeah.

There's Genomes England, and now Our Future Health, which a lot of people don't know about here, which is well into the 5 million people enrollment.

Can you tell us about, you know, this is now 15 years ago plus when these were started, and of course now with a new one that's the biggest ever.

What was your thinking and involvement in how you built the UK to be a world leader in this space?

It really is.

I'm just blown away by the progress you've made.

And what was interesting, too, besides you all weren't complacent about, oh, we got this UK biobank, and you just kept forging ahead.

And by the way, I really share this importance of finally what has been a fantasy of primary prevention, which I never really achieved.

It's always, oh, after a heart attack, then only you know.

But that's what I wrote about in Super Ager's book, and I'll get you a copy.

Yeah, absolutely.

And what we've learned, you know, for example, from the UK biobank is not just, of course, the genomics that you touched on, but the proteomics.

Yeah, the organ clocks and all these other layers of data.

So that gets me to my next topic, which I know you're all over it, which is AI.

So when I did the NHS review back in 2018, 2019,

The group of people, which were amazing, that I had to work with, no doubt why the UK punches well beyond its weight.

I had about 50 people, and they just said, you know what?